Lv6
3130 积分 2024-04-07 加入
Methodological considerations in the interpretation of ASCENT-03
16天前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
18天前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
18天前
已完结
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
27天前
已完结
The changing therapeutic landscape of small-cell lung cancer
29天前
已完结
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
1个月前
已完结
The next generation of antibody–drug conjugates
2个月前
已完结
Antibody-drug conjugates-related interstitial lung diseases: data mining of the FAERS database
2个月前
已完结
Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2个月前
已完结
The Incidence of Birthmarks in the Neonate
2个月前
已完结
皖公网安备34019202002308
